explore -WSS

explore

author：Wikipedia 2025-10-01 00:06:42 - browse：9561

Photograph of an abandoned lab with empty bottle, boxes, and beakers all around. -- biotech coverage from STAT — Adobe

SAN DIEGO — It was spring 2020, and Histogen, a small biotech with big ambitions to regenerate tissues throughout the body and turn a profit in the process, had just gone public. The company’s leadership believed they were poised for success — until everything slowly and irreversibly fell apart.

Three years later, Histogen no longer develops therapies. It has abandoned efforts to reverse baldness, replenish cartilage in achy knees, and quell infection and inflammation.

The company has no lab. It has no headquarters. It has just two employees, including a chief financial officer who also serves as secretary, CEO, and president. Histogen’s stock trades below $1 a share. And even that is coming to a close. On Thursday, the Nasdaq suspended trading of Histogen shares after determining that the company’s operations and assets are negligible, meaning the biotech is now officially a shell of its former self.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Wegovy leads to weight loss. Can it treat depression, too?

entertainment

WSS

Apple is now the first public company to be valued at $3 trillion

Drug repurposing or repositioning? The language matters

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Malaria cases in Florida and Texas: Here’s what you need to know

FTC sues over Novant Health acquisition of two N.C. hospitals

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

knowledge

explore

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Psychedelics group wrestles with new pharma identity

Wildfire smoke exposes gaps in outdoor worker protections

Reconstructing family trees of blood cells may help predict disease

Activists slam private health insurers over coverage restrictions

United colonoscopy coverage change 'may cost lives,' doctors say

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Jerome Adams on the need for new antivirals for Covid

focus

Biogen walks away from Aduhelm, years after polarizing approval

Novavax promises a turnaround & Lilly roils the obesity market

Hepatitis C has a cure — but many Americans still lack access to it

Zyn nicotine pouches become unlikely player in latest culture war

Supreme Court strikes down use of affirmative action

How one medical school became remarkably diverse

hotspot

entertainment

hotspot

Wikipedia